GO
Loading...

Drug Retail

More

  • CHICAGO, Oct 27- U.S. drugstore chain Rite Aid Corp will ban Apple Inc's new electronic payments service in its 4,572 stores as it commits to joining a consortium of other large retailers developing a rival payments system. The rival system, called Current C, is being developed by Merchants Customer Exchange, a consortium of merchants that includes Rite Aid and...

  • Drugmakers want indemnity  Thursday, 23 Oct 2014 | 1:38 PM ET

    Drug companies may be looking for legal protection amid a massive demand for Ebola vaccines, reports CNBC's Meg Tirrell.

  • Former Walgreen CFO sues company for defamation Friday, 17 Oct 2014 | 7:59 AM ET

    Walgreen's former CFO sued the drugstore operator, alleging executives defamed him in news reports that blamed him for errors in its forecast.

  • GW Pharma: Focused on epilepsy  Tuesday, 14 Oct 2014 | 5:22 PM ET

    GW Pharma shares are down sharply after a study of its treatment for ulcerative colitis missed its primary endpoint in a mid-stage trial. GW Pharmaceuticals CEO Justin Gover, says the company's main focus is on its product for epilepsy.

  • Cannabis Expo: Pet food & more  Monday, 13 Oct 2014 | 8:57 AM ET

    CNBC's Kate Rogers reports from the East Coast Cannabis Business Expo, on one pot entrepreneur taking CBD, which is an extract of the hemp plant, and putting it in pet food.

  • Weed, Inc.: The business of legal marijuana  Thursday, 9 Oct 2014 | 7:00 AM ET

    Medical marijuana, which is legal in 23 states and Washington, D.C., and recreational marijuana -- legal in Colorado and Washington State -- bring dispensaries and states healthy revenues, via taxes and fees. Watch a 90-second overview of the business of legal marijuana by the numbers.

  • Oct 8- Canadian pharmacy chain Jean Coutu Group Inc reported a 3 percent rise in quarterly revenue as an increase in the number of franchised stores helped offset the impact of higher sales of generic drugs. Price-controls for generic drugs, aimed at cutting costs for government and private health programs, have also hurt Jean Coutu and rivals such as Shoppers...

  • Jean Coutu's sales rise 3 pct Wednesday, 8 Oct 2014 | 7:20 AM ET

    Oct 8- Canadian pharmacy chain Jean Coutu Group Inc reported higher quarterly sales, helped by demand for generic drugs and the expansion of its network of franchised stores. Net profit fell to C $53.6 million, or 28 Canadian cents per share, in the quarter ended Aug. 30, from C $208.2 million, or 99 Canadian cents per share, a year earlier. The company had reported a gain...

  • Oct 1- Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, said Walgreen Co would sell prescription drugs under its two Medicare Part D plans for 2015..

  • Sept 30- U.S. drugstore chain Walgreen Co said lower insurer payments for prescriptions amid increased competition, and a rise in generic drug prices would continue to hurt margins in the current quarter, pressing its shares. Pharmacy chains such as Walgreen are contracted with health insurers and others that operate Medicare Part D drug plans.

  • Sept 30- U.S. drugstore chain operator Walgreen Co reported its biggest jump in quarterly sales in three years, helped by higher prescription sales, sending its shares up more than 3 percent in premarket trading. Walgreen ended the year with a record 856 million filled prescriptions.

  • Sept 30- U.S. drugstore chain operator Walgreen Co reported a 6.2 percent rise in quarterly sales, helped by higher prescription sales, sending its shares up more than 3 percent in premarket trading.

  • Problems for potpreneurs  Wednesday, 24 Sep 2014 | 1:54 PM ET

    CNBC's Kate Rogers reports on the uphill battle facing potpreneurs.

  • Tekmira soars on FDA news  Monday, 22 Sep 2014 | 2:05 PM ET

    Tekmira said regulators in the U.S. and Canada authorized use of its experimental drug for Ebola through an expanded access program. CNBC's Meg Tirrell provides insight.

  • High at work  Thursday, 18 Sep 2014 | 1:54 PM ET

    A new survey from Mashable finds nearly 10 percent of Americans admit to smoking pot before heading into the office. CNBC's Kate Rogers shares the difficulties in testing employees.

  • Sept 18- Rite Aid Corp cut its full-year profit forecast for the second time in about three months due to lower margins in its pharmacy business, sending its shares down more than 16 percent.

  • Sept 18- Rite Aid Corp, the third-largest U.S. drugstore chain, cut its full-year profit forecast for the second time, citing lower margins in its pharmacy business, sending its shares down 11 percent in premarket trading.

  • Rite Aid cuts full-year profit forecast for second time Thursday, 18 Sep 2014 | 7:27 AM ET

    Sept 18- Rite Aid Corp, the third largest U.S. drugstore chain, cut its full-year profit forecast for the second time this year as lower margins from its pharmacy business continue to eat into earnings. Rite Aid shares fell nearly 9 percent in premarket trading on Thursday after the company also shaved the top end of its sales forecast.

  • Avanir up on Alzheimer's trial  Monday, 15 Sep 2014 | 1:03 PM ET

    Avanir Pharma is up more than 60 percent, after the company said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. CNBC's Meg Tirrell speaks to the company's CEO Keith Katkin.

  • Orexigen's obesity pill  Thursday, 11 Sep 2014 | 1:11 PM ET

    Orexigen's obesity pill is called Contrave, and it's been approved in the U.S. CNBC's Meg Tirrell reports.